[Brain natriuretic peptide as marker and factor of prognosis in chronic heart failure].
The role of natriuretic peptides in pathogenesis of chronic heart failure (CHF) is reviewed. Main attention is given to significance of measurement of brain natriuretic peptide in the following clinical situations related to CHF: diagnosis of CHF, screening of patients with symptomless left ventricular dysfunction, differential diagnosis of edematous syndrome, indications to therapy and monitoring of its effectiveness, assessment of long term prognosis of patients with CHF. Possibilities of curative use of natriuretic peptides and inhibitors of vasopeptidases are also discussed.
M A
MA
Bugrimova
N M
NM
Savina
O S
OS
Vanieva
B A
BA
Sidorenko
D015415:Biomarkers / Q000097:blood; D018450:Disease Progression; D006333:Heart Failure / Q000097:blood*; D006801:Humans; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D011379:Prognosis
D015415:Biomarkers; D020097:Natriuretic Peptide, Brain